GlassScriptPhysician profile
Alexandra Salisbury
NPI 1497351167
$2,094.43
in general payments reported to CMS, 2019-2025
11 companies · $1,101 in 2025
The $1,101 reported for 2025 was more than what 91% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $261 · 2022: $291 · 2023: $164 · 2024: $277 · 2025: $1,101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $960 · Food and Beverage: $583.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $960.00 |
| Food and Beverage | $582.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $960.00 | 2025 | Venacure 1470 Pro |
| Integra Lifesciences Corporation | $424.64 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Smith+Nephew, INC. | $239.31 | 2022-2024 | Collagenase Santyl, Oasis, Versajet |
| Tactile Systems Technology INC | $141.08 | 2025 | Nimbl, Flexitouch Plus |
| Baxter Healthcare | $113.10 | 2021 | |
| Galderma Laboratories, L.P. | $92.09 | 2023 | |
| Paratek Pharmaceuticals, INC. | $35.65 | 2022 | |
| Mentor Worldwide LLC | $27.36 | 2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Solventum Corporation | $21.94 | 2024 | Activ.A.C., V.A.C. Dermatac |
| Convatec INC. | $20.05 | 2022 | |
| Bsn Medical INC | $19.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Salisbury listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.